提醒

Fortress Biotech Inc. (FBIO)

NasdaqCM: FBIO · 即時價格 · USD

2.71

+0.10 (3.83%)

收盤時： Aug 12, 2026, 1:26 PM

3.83% (1D)

買價	1.93
市值	89.86M
營收 (ttm)	66.16M
淨利（ttm）	119.2M
貝塔	1.21
EPS (ttm)	3.23
本益比（ttm）	0.84
正向 PE	-1.54
P/B (ttm)	0.55
P/S (ttm)	1.36
Earnings Date	Aug 13, 2025

賣價	3.31
成交量	470,160
20 日平均成交量	579,204
打開	2.61
上一頁關閉	2.61
日間範圍	2.57 - 2.73
52 週範圍	1.90 - 4.53
分析師	n/a
目標價	11 (305.90%)
股利	n/a
Ex-股利日期	n/a

關於FBIO

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical ...

[閱讀更多]

工業 Biotechnology

部門 Healthcare

IPO 日期 Nov 17, 2011

員工 78

證券交易所 NasdaqCM

股票代號 FBIO

網站 https://www.fortressbiotech.com

完整的公司簡介

財務表現

Fortress Biotech 在 2025 年的營收為 63.26M，較前一年的 57.67M 增加 9.69%。淨利為 6.82M，較前期減少 -114.82%。

財務報表

分析師預測

根據2 分析師評等，FBIO股票的平均評等為「null」。 12個月股價預測為11，與最新價格相比為上漲空間的305.9%。

股票預測

獲利驚喜

Fortress Biotech 已於 May 14, 2026 公布季度財報：

營收的 $16.04M 錯過估計 $0, 與 22.06% YoY 成長.

EPS 的 2.82 超出估計 3.04, 與 687.50% YoY 成長.

下次財報發布

Fortress Biotech Inc. 定於發布財報 Aug 13, 2025, 收盤後。
分析師預估營收 ... 升級

新聞動態

1 月前 · Simply Wall St.

Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes

Journey Medical is back in focus as analysts revisit their price targets in light of fresh information around its role inside Fortress Biotech and the implied value of its shares and cash position. Re...

5 月前 · TipRanks

Fortress Biotech’s Cyprium enters agreement to sell PRV for $205M

Fortress Biotech (FBIO) and its majority-owned subsidiary, Cyprium Therapeutics announced that Cyprium entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Re...

6 月前 · Simply Wall St.

Fortress Biotech, Inc. (NASDAQ:FBIO) Could Be Less Than A Year Away From Profitability

We feel now is a pretty good time to analyse Fortress Biotech, Inc.'s ( NASDAQ:FBIO ) business as it appears the...

9 月前 · Zacks

Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates

Fortress Biotech (FBIO) delivered earnings and revenue surprises of +125.58% and -25.55%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock...

9 月前 · Associated Press Finance

Fortress Biotech: Q3 Earnings Snapshot

BAY HARBOR ISLAND, Fla. AP) — Fortress Biotech Inc. FBIO) on Friday reported earnings of $5.9 million in its third quarter.

第 1 頁，共 2 頁

Fortress Biotech Inc. (FBIO)